Johan Svensson Pages 2023 - 2032 ( 10 )
Potent antiresorptive agents have been developed for the treatment of osteoporosis and bone disorders. There are few agents available that stimulate bone formation. Recently, treatment with parathyroid hormone was found to induce a potent increase in hip and lumbar bone mineral density (BMD). The present review focus on growth hormone (GH) / growth hormone secretagogues (GHSs). GH / GHSs stimulates bone turnover, thereby increasing bone mass and density.
Growth hormone,secretagogue,bone mineral content,bone mineral density
Research Centre for Endocrinology and Metabolism, Grona Straket 8, Sahlgrenska University Hospital, SE-413 45 Goteborg, Sweden.